Comparative Biodistribution of 89Zr-ofatumumab and 225Ac-ofatumumab for Lymphoma Radioimmunotherapy

体内分布 拉吉细胞 放射免疫疗法 淋巴瘤 单克隆抗体 药代动力学 医学 化学 最大值 药理学 抗体 分子生物学 免疫学 生物化学 生物 体外
作者
Mark S. Longtine,Mark J. Hoegger,Diane S. Abou,Kyu-Hwan Shim,Daniel L.J. Thorek,Richard L. Wahl
出处
期刊:The Journal of Nuclear Medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:61: 381-381 被引量:1
摘要

381 Objectives: Immunotherapies that target the CD20 protein present on most non-Hodgkins lymphoma (NHL) cells have greatly improved outcomes. However, as many patients are refractory or undergo relapse, current treatments are inadequate. Our previous work showed that 89Zr-labeled ofatumumab (Ofa), a next-generation, fully human anti-CD20 antibody, effectively targets lymphoma xenografts (Yoon et al, 2018, JNM). Here, we describe characterization of Ofa labeled with Actinium-225 (225Ac-Ofa), which emits 4 cell-killing alpha particles per decay and compare tumor targeting and biodistribution of 225Ac-Ofa with 89Zr-Ofa. 225Ac-Ofa has potential advantages over previous beta-particle-based radioimmunotherapies for NHL. Methods: DOTA was conjugated to Ofa at an 8:1 molar ratio. 225Ac was chelated and 225Ac-Ofa purified by size exclusion chromatography (SEC). Radiochemical yield was assayed by iTLC and radiochemical purity by iTLC and fast protein liquid chromatography (FPLC). Immunoreactivity was assayed by binding to Raji B-cell lymphoma cells. Stability in human serum was assayed by iTLC. Raji-luc tumor-cell killing by 225Ac-Ofa was evaluated by MTS and bioluminescence assays. 89Zr-Ofa was prepared as described (Yoon et al.). Mice with subcutaneous Raji xenografts were injected IV with 300 nCi (10 µg) 225Ac-Ofa (n=4), 100 µCi (10 µg) 89Zr-Ofa (n=3) or 300 nCi free 225Ac (n=5). Naive mice were injected IV with 225Ac-Ofa (n=4) or 89Zr-Ofa (n=4). Biodistribution in 20 organs/tissues were determined 7 d post-injection as % injected dose/gram. Results: We obtained 225Ac-Ofa (n=5) with radiochemical yields of 36±6% and >98% radiochemical purity. FPLC confirmed >98% of the 225Ac was bound to Ofa. Specific activity was >100 nCi/µg. 225Ac-Ofa immunoreactivity was >65%, similar to 89Zr-Ofa. Serum stability was 70-90% after 10 d at 37°C (n=3). 225Ac-Ofa showed potent and dose-dependent killing of Raji-luc cells at concentrations from 10-100 nCi/ml vs. 225Ac-IgG or unlabeled Ofa (p 0.05) to 89Zr-Ofa (43±13% ID/g). Biodistribution was also not statistically different between 225Ac-Ofa and 89Zr-Ofa in liver (31±6 vs. 21±2% ID/g), blood (10±3 vs. 9±2% ID/g), spleen (31±6 vs. 21±3 % ID/g), bone marrow (7±2 vs. 8±2 % ID/g) or other issues analyzed. In tumor-bearing mice, free 225Ac accumulated to high levels in the liver (64±19% ID/g), significantly (p 0.05) localizations to blood (16±1 vs. 13±2% ID/g), liver (10±2 vs. 9±1% ID/g), spleen (34±6 vs. 22±7% ID/g), bone marrow (15±8 vs. 10±4% ID/g) and other tissues. Conclusions: 225Ac-Ofa was obtained with high radiochemical purity, immunoreactivity and in vitro stability. 225Ac-Ofa showed high potency in specifically killing CD20-expressing lymphoma cells in vitro. 225Ac-Ofa specifically targeted CD20-expressing lymphoma xenografts, similar to the targeting observed by 89Zr-Ofa, and 225Ac-Ofa vs. 89Zr-Ofa showed highly similar biodistributions to non-target organs/tissues. Together, these results suggest 225Ac-Ofa has considerable potential for radioimunotherapy of non-Hodgkin lymphoma and that 89Zr-Ofa and 225Ac-Ofa may form a theranostic (imaging and therapeutic) pair for these patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Miayoyo完成签到,获得积分20
刚刚
naitangkeke完成签到,获得积分10
刚刚
爆米花应助yxy采纳,获得30
1秒前
1秒前
1秒前
白漠雪完成签到,获得积分10
1秒前
wangjiangtao发布了新的文献求助20
2秒前
2秒前
2秒前
2秒前
2秒前
王雯发布了新的文献求助10
2秒前
tingting完成签到,获得积分10
3秒前
隐形惜筠完成签到,获得积分10
3秒前
昭玥完成签到,获得积分10
3秒前
4秒前
wenwenTang发布了新的文献求助30
4秒前
stt发布了新的文献求助10
4秒前
4秒前
5秒前
5秒前
sharon完成签到,获得积分10
5秒前
上官若男应助沉默的尔槐采纳,获得10
5秒前
Orange应助Miayoyo采纳,获得10
6秒前
6秒前
bkagyin应助zz采纳,获得10
7秒前
77发布了新的文献求助10
7秒前
NIUBEN发布了新的文献求助10
7秒前
tingting发布了新的文献求助10
7秒前
8秒前
8秒前
美好丹妗完成签到,获得积分10
8秒前
狄谷南发布了新的文献求助10
8秒前
zzz发布了新的文献求助10
9秒前
9秒前
xia发布了新的文献求助10
9秒前
znn发布了新的文献求助10
9秒前
桐桐应助昵昵昵昵呀采纳,获得10
10秒前
log发布了新的文献求助10
10秒前
TGU2331161488发布了新的文献求助10
10秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974712
求助须知:如何正确求助?哪些是违规求助? 3519159
关于积分的说明 11197254
捐赠科研通 3255257
什么是DOI,文献DOI怎么找? 1797724
邀请新用户注册赠送积分活动 877130
科研通“疑难数据库(出版商)”最低求助积分说明 806132